BSE Live
Nov 10, 16:01Prev. Close
3098.35
Open Price
3058.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 10, 15:52Prev. Close
3096.70
Open Price
3084.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3089.40 (535)
| Balance Sheet of Dr Lal PathLabs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 83.35 | 83.34 | 83.33 | 83.07 | 82.68 | |
| Total Share Capital | 83.35 | 83.34 | 83.33 | 83.07 | 82.68 | |
| Reserves and Surplus | 916.70 | 862.15 | 704.52 | 512.45 | 423.94 | |
| Total Reserves and Surplus | 916.70 | 862.15 | 704.52 | 512.45 | 423.94 | |
| Total Shareholders Funds | 1,032.95 | 945.50 | 787.85 | 595.52 | 506.62 | |
| Minority Interest | 21.20 | 5.48 | 3.79 | 2.44 | 2.89 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 93.00 | 1.22 | 7.95 | 7.30 | 24.01 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 | |
| Total Non-Current Liabilities | 93.00 | 1.22 | 7.95 | 7.30 | 24.21 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 117.70 | 79.80 | 65.45 | 52.38 | 42.27 | |
| Other Current Liabilities | 94.16 | 45.12 | 41.80 | 25.55 | 17.55 | |
| Short Term Provisions | 15.40 | 13.38 | 8.71 | 6.91 | 30.97 | |
| Total Current Liabilities | 227.26 | 138.30 | 115.96 | 84.84 | 90.78 | |
| Total Capital And Liabilities | 1,374.40 | 1,090.50 | 915.55 | 690.09 | 625.23 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 291.70 | 160.12 | 159.79 | 107.91 | 108.26 | |
| Intangible Assets | 44.10 | 20.57 | 19.82 | 16.64 | 15.66 | |
| Capital Work-In-Progress | 10.40 | 3.44 | 9.56 | 15.65 | 4.09 | |
| Fixed Assets | 347.20 | 184.13 | 189.17 | 142.07 | 128.01 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 22.90 | 21.46 | 16.92 | 13.71 | 12.05 | |
| Long Term Loans And Advances | 0.10 | 0.01 | 0.06 | 0.04 | 15.91 | |
| Other Non-Current Assets | 34.30 | 43.30 | 58.47 | 39.84 | 3.81 | |
| Total Non-Current Assets | 481.70 | 276.87 | 292.53 | 223.53 | 201.50 | |
| CURRENT ASSETS | ||||||
| Current Investments | 164.30 | 184.78 | 144.80 | 106.08 | 64.32 | |
| Inventories | 57.00 | 28.54 | 27.34 | 17.91 | 14.52 | |
| Trade Receivables | 51.40 | 53.22 | 41.16 | 41.80 | 36.31 | |
| Cash And Cash Equivalents | 569.10 | 490.24 | 313.51 | 239.52 | 229.64 | |
| Short Term Loans And Advances | 0.90 | 0.94 | 0.25 | 0.18 | 72.30 | |
| OtherCurrentAssets | 50.00 | 55.92 | 95.97 | 61.07 | 6.65 | |
| Total Current Assets | 892.70 | 813.63 | 623.02 | 466.56 | 423.74 | |
| Total Assets | 1,374.40 | 1,090.50 | 915.55 | 690.09 | 625.23 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 19.80 | 9.30 | 8.51 | 32.64 | 23.96 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 50.32 | 50.32 | 50.32 | 50.32 | 50.32 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 64.49 | |
| Current Investments Unquoted Book Value | 164.30 | 184.78 | 144.80 | 106.08 | 64.32 |
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak